LGR4 expression is upregulated in cancers, including breast, prostate, MM, colon, lung adenocarcinomas and high-grade plasmacytoid ovarian cancer, and plays a role in tumor progression, invasion, and metastasis (58–64). Here, LGR4 is linked to neoplasm.